Epilovar (Sodium Valproate)
The most likely mode of action for sodium valproate is potentiation of the inhibitory action of gamma aminobutyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.
Share Now
Additional Information
| Name | Epilovar PR 500 mg |
| Description | Pharmacotherapeutic group: Anti-epileptics, ATC Code: N03AG01 The most likely mode of action for sodium valproate is potentiation of the inhibitory action of gamma aminobutyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. In certain in-vitro studies it was reported that sodium valproate could stimulate HIV replication but studies on peripheral blood mononuclear cells from HIV infected subjects show that sodium valproate does not have a mitogen-like effect on inducing HIV replication. Indeed the effect of sodium valproate on HIV replication ex-vivo is highly variable, modest in quantity, appears to be unrelated to the dose and has not been documented in man. |
| Active Ingredient | sodium valproate |
| Indication | |
| For oral administration in the treatment of generalized, partial or other epilepsy. | |
| Strengths | 500mg |
| Regulatory Status | Registered |
| Business Partner | MYLAN S.A.S |
| Origin | GERMANY |
Related Products
Related products
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.
